Drug safety evaluation of sorafenib for treatment of solid tumors: consequences for the risk assessment and management of cancer patients
暂无分享,去创建一个
F. Goldwasser | R. Coriat | B. Blanchet | A. Thomas-Schoemann | P. Boudou-Rouquette | M. Vidal | J. Durand | A. Cessot | J. Alexandre | O. Huillard | J. Giroux | Emilie Boissier